Jonathan Feelemyer, PhD, MS, MPhil
NYU School of Global Public Health - Project Director
Email: jf3880@nyu.edu
Education
PhD, Epidemiology, NYU Grossman School of MedicineMPhil, Epidemiology, NYU Grossman School of Medicine
MS, Epidemiology, University at Albany School of Public Health
BA, Health and Society, University of Rochester
Research Interests
Injecting drug use, epidemiology, HIV, HCV, sexually transmitted diseases, harm reduction, research synthesis BIO
Jonathan Feelemyer is a project director at the NYU School of Global Public Health. His research interests include HIV, hepatitis C, sexually transmitted diseases, injection drug use, and harm reduction for at risk populations. His research is focused on international settings specifically in Southeast Asia and Eastern Europe. He has published numerous publications in academic journals and has presented his work at national and international conferences. He has collaborated with researchers from New York University, Columbia University, the Centers for Disease Control and Prevention, and researchers in Estonia, Vietnam, Russia, France, and other countries. He has worked collaboratively on numerous meta-analysis and systematic review studies, synthesizing research from multiple countries and time periods examining different research topics related to HIV and HCV. He currently works with Dr. Don Des Jarlais on research projects addressing harm reduction, combined prevention, and reductions in HIV and HCV among different at risk populations, with special focus on high prevalence settings worldwide. Projects
Principal Investigator, Comparison of Stigmatization of Monkeypox, Injecting Drug Use, HIV/AIDS, and COVID-19. Active
Publications
Recent
Des Jarlais DC, Weng CA, Feelemyer J, McKnight C (2023).
COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Harm Reduction Journal, 20 (1), 63. doi: 10.1186/s12954-023-00791-0. PMCID: PMC10156073.
COVID-19 vaccination and HIV transmission among persons who inject drugs during the first two years of the COVID-19 pandemic in New York City
Harm Reduction Journal, 20 (1), 63. doi: 10.1186/s12954-023-00791-0. PMCID: PMC10156073.
Des Jarlais DC, Lieff S, Grivel M, Meltzer G, Choi J, Weng CA, Feelemyer JP, Chang VW, Yang L (2023).
COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources
PLoS One, 18 (4), e0283467. doi: 10.1371/journal.pone.0283467. PMCID: PMC10138268.
COVID-19 stigmatization after the development of effective vaccines: Vaccination behavior, attitudes, and news sources
PLoS One, 18 (4), e0283467. doi: 10.1371/journal.pone.0283467. PMCID: PMC10138268.
Wiessing L, Sypsa V, Abagiu AO, ... Feelemyer J, ...Hatzakis A..., Des Jarlais D (2023).
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel
AIDS and Behavior, 27 (4), 1140-1153. doi: 10.1007/s10461-022-03851-x. PMCID: PMC9651099.
Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV outbreaks in Europe, North America and Israel
AIDS and Behavior, 27 (4), 1140-1153. doi: 10.1007/s10461-022-03851-x. PMCID: PMC9651099.
Feelemyer J, Des Jarlais D, Nagot N, Huong DT, Oahn KTH, Khue PM, Giang HT, Thanh NTT, Cleland CM, Arasteh K, Caniglia E, Chen Y, Bart G, Moles JP, Vinh VH, Vallo R, Quillet C, Rapoud D, Le SM, Michel L, Laureillard D, Khan MR (2023).
Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam
International Journal of STD and AIDS, 34 (4), 236-244. doi: 10.1177/09564624221142366.
Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam
International Journal of STD and AIDS, 34 (4), 236-244. doi: 10.1177/09564624221142366.
Feelemyer JP, Richard E, Khan MR, Scheidell JD, Caniglia EC, Manandhar-Sasaki P, Ban KF, Charles D, Braithwaite RS (2023).
Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A meta-analysis
AIDS and Behavior [Epub 2023 Feb 14]. doi: 10.1007/s10461-023-04012-4.
Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A meta-analysis
AIDS and Behavior [Epub 2023 Feb 14]. doi: 10.1007/s10461-023-04012-4.
Notable
Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review
Addiction, 109 (1), 20-32. doi: 10.1111/add.12303. PMCID: PMC5312702.
Feelemyer J, Des Jarlais DC, Arasteh K, Phillips BW, Hagan H (2014).
Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review
Drug and Alcohol Dependence, 134, 251-258. doi: 10.1016/j.drugalcdep.2013.10.011. PMCID: PMC3880839.
Feelemyer J, Des Jarlais D, Arasteh K, Uuskula A (2015).
Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: An international systematic review
AIDS and Behavior, 19 (4), 575-583. doi: 10.1007/s10461-014-0928-3. PMCID: PMC4393761.
Jonathan Feelemyer's ResearchGate Profile